128 filings
Page 3 of 7
8-K
0guioec
8 Jun 22
Submission of Matters to a Vote of Security Holders
5:23pm
8-K
g14fas7degmswk
12 May 22
Panbela Provides Business Update and Reports Q1 2022 Financial Results
4:07pm
8-K
mszv6toih wpfu6tf
24 Mar 22
Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results
4:06pm
8-K
jdd7wj1n 4nc
22 Feb 22
Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
8:03am
8-K
6pg8uam5eq9ieoh3
10 Nov 21
Panbela Provides Business Update and Reports Q3 2021 Financial Results
4:16pm
8-K
cdgnnhn9ge3balju2g
11 Aug 21
Panbela Provides Business Update and Reports Q2 2021 Financial Results
4:13pm
8-K
ynsgw8gt4eevllas
2 Jul 21
Panbela Therapeutics Announces $5.0 Million Bought Deal Offering of Common Stock
4:06pm
8-K
nfprq7 2kpfpjxbfivp4
21 Jun 21
Regulation FD Disclosure
8:00am
8-K
epbg95kx
16 Jun 21
Regulation FD Disclosure
8:00am
8-K
i3nony2qim58pb93rzq
4 Jun 21
Regulation FD Disclosure
9:16am
8-K
qnv4gje
26 May 21
Panbela Announces Company Founder Dr. Michael T. Cullen to Serve as Chairman of the Board of Directors
8:03am
8-K
ints2
12 May 21
Panbela Provides Business Update and Reports Q1 2021 Financial Results
4:11pm
8-K
yb0y vrvc81
15 Apr 21
Panbela Announces Partial Clinical Hold Lifted on Phase I Polyamine Metabolic Inhibitor Study in Pancreatic Cancer
8:05am
8-K/A
967bqwnm6s9tv1dp7t3
26 Mar 21
Results of Operations and Financial Condition
8:40am
8-K
e5ojjk o3i8q46pj
25 Mar 21
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
12:00am
8-K
yxbb43f7u6 7u
10 Feb 21
Regulation FD Disclosure
8:45am
8-K
p979j
8 Dec 20
Regulation FD Disclosure
8:01am
8-K
3cfbqzc5qm9npe 4m1ca
2 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:55pm
8-K
4v1xy
12 Nov 20
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results
4:11pm
8-K
287bsd
14 Sep 20
Regulation FD Disclosure
8:00am